Buscar
Mostrando ítems 1-10 de 225
Treatment failure in leishmaniasis: Drug-resistance or another (epi-) phenotype?
(Taylor and Francis, 2014)
Two major leishmaniasis treatments have shown a significant decrease in effectiveness in the last few decades, mostly in the Indian subcontinent but also in other endemic areas. Drug resistance of Leishmania correlated ...
Comparison of gene expression patterns among Leishmania braziliensis clinical isolates showing a different in vitro susceptibility to pentavalent antimony
(Crambridge University Press, 2011)
Introduction. Evaluation of Leishmania drug susceptibility depends on in vitro SbV susceptibility assays, which are labour-intensive and may give a biased view of the true parasite resistance. Molecular markers are urgently ...
Determination of pentavalent antimony in antileishmaniotic drugs using an automated system for liquid-liquid extraction with on-line detection
(Elsevier Science BvAmsterdamHolanda, 2006)
Efficacy of Spironolactone treatment in murine models of Cutaneous and Visceral Leishmaniasis
(Frontiers Media, 2021)
Hepatotoxicity of pentavalent antimonial drug: possible role of residual Sb(III) and protective effect of ascorbic acid
(American Society for Microbiology, 2015)
Pentavalent organoantimonial derivatives: two simple and efficient synthetic methods for meglumine antimonate
(John Wiley & Sons LtdW SussexInglaterra, 2003)
Efficacy of pentavalent antimoniate intralesional infiltration therapy for cutaneous leishmaniasis: A systematic review.
(Public Library of Science, 2018)